Michael Scolaro

Michael Scolaro

Nov 16, 2017

Group 6 Copy 196
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Eco-friendly and affordable molecular weaponry against snails that transmit schistosomiasis

    Schistosomiasis is a disease transmitted by snails, responsible for chronic illness of many millions of...

    Can plant-based antimicrobials act as an alternative to therapeutic antibiotics?

    Antibiotic overuse has led to antimicrobial resistance (AMR). The World Health Organisation (WHO) ranks...

    Does Zika virus suppress the antiviral host response in neuronal cells?

    Zika virus is spreading rapidly in the Western hemisphere and is linked to fetal microcephaly. We recently...

    Backer Badge Funded